This European 3 year programme, starting from September 2013, aims at developing point of care (PoC) predictive and prognostic tests that will enable tangible improvements in the health and quality of life of chronic hepatitis C patients.

PoC-HCV will capitalise and translate promising discoveries made in the context of the SPHINX FP7 project which identified biomarkers useful in the management of patients infected by hepatitis C virus.


PoC-HCV is a European research project supported
by the European Commission (Grant agreement n° 601851).